abstract |
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and omega-(methylsulfonyl)alkylamine or omega-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering omega-(methylsulfonyl)alkylamine or omega-(methylsulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. |